Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.970
-0.070 (-1.73%)
At close: Dec 18, 2025, 4:00 PM EST
3.970
0.00 (0.00%)
After-hours: Dec 18, 2025, 5:21 PM EST
Evolent Health Employees
Evolent Health had 4,500 employees as of December 31, 2024. The number of employees decreased by 200 or -4.26% compared to the previous year.
Employees
4,500
Change (1Y)
-200
Growth (1Y)
-4.26%
Revenue / Employee
$456,456
Profits / Employee
-$40,197
Market Cap
443.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,500 | -200 | -4.26% |
| Dec 31, 2023 | 4,700 | -400 | -7.84% |
| Dec 31, 2022 | 5,100 | 1,600 | 45.71% |
| Dec 31, 2021 | 3,500 | 600 | 20.69% |
| Dec 31, 2020 | 2,900 | -500 | -14.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVH News
- 5 weeks ago - Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden - PRNewsWire
- 6 weeks ago - Evolent Announces Third Quarter 2025 Results - PRNewsWire
- 2 months ago - Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - PRNewsWire
- 3 months ago - Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners - PRNewsWire
- 4 months ago - Evolent's Soft Q2 Results: Why I'm Holding Anyway - Seeking Alpha
- 4 months ago - Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock - PRNewsWire